Comments*

 
  • Physiology

  • Events 

    Wednesday, January 20, 2010 | 1:00 PM - 5:45 PM

    The Metabolome: A Window on Cell Physiology and Portal to Understanding Complex Biological Systems, Diseases and Therapies

    Organizers: Steven Gross (Weill Cornell Medical College) and Kyu Rhee (Weill Cornell Medical College)

    This symposium will review recent technical and conceptual advances that highlight the unique, but largely unrecognized, potential of the metabolomics arm of systems biology.

    Friday, January 29, 2010 | 1:00 PM - 5:00 PM

    Cardiovascular Protection and the Renin-Angiotensin System

    Organizers: Katalin Kauser (Boehringer Ingelheim Pharmaceuticals) and Christine Teutsch (Boehringer Ingelheim Pharmaceuticals)

    The renin-angiotensin system is critical to blood pressure control. This symposium will highlight the importance of blocking the deleterious effects of Angiotensin II and describe a mechanistic basis for a more generalized cardiovascular protection.

    Tuesday, February 9, 2010 | 1:00 PM - 5:00 PM

    Circadian Cycle and Metabolic Dysfunction

    Speakers: Joe Bass (Northwestern University), Carla B. Green (University of Texas Southwestern Medical Center), Pere Puigserver (Dana-Farber Cancer Institute)

    This symposium will bring together leading researchers to examine the link between metabolic function, internal biological timing and the physiological consequences of circadian disruption.

  • Past Events

    October 28 - 30, 2009

    4th International Conference on Oxidative/Nitrosative Stress and Disease

    Organizers: Debra L. Laskin (Rutgers University), Howard Kipen (UMDNJ-Robert Wood Johnson Medical School),Val Vallyathan (NIOSH/CDC), Vince Castranova (NIOSH/CDC), Andrew J. Gow (Rutgers University), Jeffrey D. Laskin (UMDNJ-Robert Wood Johnson Medical School), and Diane E. Heck (New York Medical College)

    The symposium will integrate basic science and clinical research so that both bench researchers and clinicians can discuss the role of reactive oxygen and nitrogen species in inflammation and lung disease.

    Tuesday, October 27, 2009 | 1:00 PM - 5:00 PM

    Is Alzheimer's Disease Type 3 Diabetes?

    Speakers: Suzanne M. de la Monte (Brown Medical School), William L. Klein (Northwestern University), José A. Luchsinger (Columbia University), Mark Mattson (National Institute on Aging, NIH)

    Alzheimer’s disease (AD) has been called Type 3 diabetes, unique to the brain; others suggest that diabetes is a risk factor for AD. This symposium will discuss the significance of cerebral metabolic disturbances in Alzheimer's disease.

    October 21 - 24, 2009

    Ninth Cooley's Anemia Symposium

    Organizers: Elliott Vichinsky (Children's Hospital and Research Center, Oakland, CA), Ellis Neufeld (Children's Hospital Boston)

    This symposium will illuminate many unsolved but critically important issues in the understanding and treatment of thalassemia, thus offering the scientific, clinical, caregiving, and patient communities the most up-to-date exchange on the current and future perspectives of the disease.

    Wednesday, September 30, 2009 | 8:30 AM - 7:00 PM

    Parkinson's Disease Therapeutics Conference

    Chair: J. William Langston (The Parkinson's Institute and Clinical Center)

    Held in partnership with the Michael J. Fox Foundation, this meeting will highlight novel advances in basic and translational research that impact understanding of Parkinson's Disease and its treatment.

  • Publications 

    eBriefing

    Type 2 Diabetes Disparities in Ethnic Minorities: Origin, Challenges, and Solutions

    Organizer: Mary Ann Banerji, MD (SUNY Downstate Medical Center)

    Minority populations in the United States bear a disproportionate burden of diabetes and related conditions. As a new eBriefing reports, the causes include genetics, social factors, and a need for more culturally sensitive approaches from the healthcare industry.

    Annals

    Hypoxia and Consequences: From Molecule to Malady

    Edited by Chris Peers (School of Medicine, University of Leeds, Leeds, UK), Gabriel G. Haddad (University of California, San Diego, California), and Navdeep S. Chandel (Northwestern University, Evanston, Illinois)

    This Annals volume explores the transcriptional and pathophysiological responses to hypoxia and of the sensing mechanisms responsible for detection of oxygen level changes in the body.

    Annals

    Integrative Physiology

    Edited by Gerard Karsenty (Columbia University, New York, New York)

    Contributions from top researchers summarize the state of the art in the field of integrative physiology and speculate on how the field might move forward.

    Special online volume

    Annals

    Longevity, Regeneration, and Optimal Health: Integrating Eastern and Western Perspectives

    Edited by William C. Bushell (Massachusetts Institute of Technology), Erin L. Olivo (Columbia University), and Neil D. Theise (Beth Israel Medical Center, Albert Einstein College of Medicine)

    The reports in this volume establish a basis for a program of research that will advance our current understanding of longevity and health.

    Annals

    International Symposium on Olfaction and Taste

    Edited by Thomas Finger (Department of Cell and Developmental Biology, University of Colorado, Denver, Colorado)

    The collection of papers in this Annals volume provides an integrative approach to modern research in the field of the chemical senses, including smell and taste in disease, nutrition, and social interactions in humans as well as animals.

  • Webinar Archives

    Webinar Archive
    October 27, 2009

    Is Alzheimer's Disease Type 3 Diabetes?

    What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.